An integrated investigation of 16S rRNA gene sequencing and proteomics to elucidate the mechanism of Corydalis bungeana Turcz. on dextran sulfate sodium-induced colitis

• Published in: Biomedicine & pharmacotherapy Vol. 167; p. 115550
• Main Authors: Gao, Chang, Ni, Bin, Lu, Xiaolu, Guo, Chunyu, Wei, Guilin
• Format: Journal Article
• Language: English
• Published: Elsevier Masson SAS 01-11-2023; Elsevier
• Subjects: 16S rRNA sequencing; Corydalis bungeana Turcz; Gut microbiota; Proteomics; Ulcerative colitis; Gut microbiota; Corydalis bungeana Turcz; 16S rRNA sequencing; Proteomics; Ulcerative colitis
• ISSN: 0753-3322; 1950-6007
• DOI: 10.1016/j.biopha.2023.115550

Corydalis bungeana Turcz. (CBT) is frequently used to treat inflammatory illnesses, the mechanisms underlying its use to ulcerative colitis (UC) remain unclear. A dextran sulfate sodium (DSS)-induced UC mice model was established. The disease activity index (DAI), colonic length, histological inspection by hematoxylin-eosin staining, the cytokines levels in the colon, proteomics and intestinal flora in mice were investigated to evaluate the effect of CBT. The results showed that CBT can significantly reduce the DAI, increase the length of colon, improve the pathological injury of colon tissue, decrease the level of TNF-α, IL-6, IL-1β and increase the level of IL-10 in UC mice. Gut microbe sequencing showed that CBT could enhance the abundance of the intestinal microbiome, decrease possibly harmful bacteria and promote potentially helpful microbes. Proteomics investigation showed that 20 overlapping differentially expressed proteins (DEPs) were discovered in the control, model, and CBT administration groups. The DEPs in the CBT administration group were connected to biological procedures mainly involving detoxification. Extracellular matrix (ECM) receptor-associated proteins such as Col6a1 and CD36 may be important targets for CBT treatment of UC. Overall, this integrated methodology identified a comprehensive multi-omics network, composed of a certain set of gut microbiota and proteins, which may be potential targets for CBT treatment with UC.